Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Do astrocytes play a role in the initiation and progression of Parkinson’s disease? Wilson et al. reveal activation of astrocytes in early Parkinson’s disease, likely in response to the presence of abnormal proteins. Loss of astrocytes occurs upon disease progression, however, and correlates with increasing cognitive impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A fast diffeomorphic image registration algorithm
Ashburner, J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.007 · Cited by 8,122
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“Similar to the M1/M2 phenotypes of microglia, astroglia also harbour different isoforms of reactivity (Paolicelli et al. , 2011).”
ResultThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Genomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404 · cited 1×
“In contrast A2 astroglia, which is the neuroprotective phenotype, upregulate many neurotrophic factors such as CLCF1, LIF and IL-6, which promote the survival and growth of neurons as well as synaptic repair (Zamanian et al. , 2012).”
BackgroundMicroglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645 · cited 1×
“Astroglial cells can also activate micro-glial cells (Gu et al. , 2010; Halliday and Stevens, 2011; Schmidt et al. , 2011), and vice versa with microglial activation inducing astrogliosis (Balasingam et al. , 1996; Hanisch, 2002; Rohl et al. , 2007).”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 1×
“…cytokines, nitric oxide and reactive oxygen spe- cies, which can have detrimental effects in chronic neuroinflammation (Neumann et al., 2002; Deshpande et al., 2005; Mizuno et al., 2005; Zhang et al., 2005; Qian and Flood, 2008; Dean et al., 2010; Lee et al., 2010; Qian et al., 2010).”
BackgroundLee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · cited 3×
“Moreover, pro- gressive neurodegeneration has been shown to be related to astrocyte dysfunction and the expression of inflammatory molecules by astrocytes leading to microglial activation (Gu et al., 2010; Lee et al., 2010).”
BackgroundBraak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462 · cited 4×
“In post-mortem Parkinson’s brains, -synuclein inclusions have been reported within astroglia (Braak et al., 2007).”
BackgroundInfluentialdi Domenico, A., Carola, G., Calatayud, C., Pons-Espinal, M., Muñoz, J. P., Richaud-Patin, Y., Fernandez-Carasa, I., Gut, M., Faella, A., Parameswaran, J., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.011 · Cited by 372
Koprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355
Glutamate Transporters in Neurologic Disease
Maragakis, N. J., & Rothstein, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.365 · Cited by 324 · cited 3×
“…functions by clearing excess glutamate from the extracellular space by the glutamate transporter-1 to protect against excitotoxicity (Maragakis and Rothstein, 2001), suggesting that astroglia dysfunction and loss of this neuroprotective function may be particularly relevant to…”
BackgroundMicroglial activation in Parkinson’s disease using [18F]-FEPPA
Ghadery, C., Koshimori, Y., Coakeley, S., Harris, M., Rusjan, P., Kim, J., Houle, S., & Strafella, A. P. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0778-1 · Cited by 113 · cited 1×
“Increased microglial activation has been previously demonstrated in vivo with 11 C-PK11195, 18 F-FEPPA and 11 C-DPA713 PET imaging, further supporting the role of neuroinflammation in Parkinson’s pathophysiology (Ouchi et al. , 2005; Terada et al. , 2016; Ghadery et al. , 2017; Kang et al. , 2018).”
The effect of activated microglia on astrogliosis parameters in astrocyte cultures
Röhl, C., Lucius, R., & Sievers, J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.057 · Cited by 98
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Astrocytes in the initiation and progression of epilepsy
Vezzani, A., Ravizza, T., Bedner, P., Aronica, E., Steinhäuser, C., & Boison, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00727-5 · Cited by 272
Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
Garland, E. F., Hartnell, I. J., & Boche, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824888 · Cited by 165
“detected in all cortical regions as well as in the brainstem in early disease patients, but reductions compared to control were found in moderate/advanced disease (Wilson et al., 2019), re-enforcing the idea of astrocytes becoming dysfunctional as the disease progresses.”
BackgroundPET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102
“Type-2 imidazoline receptor, a newly discovered target for imaging astrocyte, is now being evaluated for its potential in differentiating AD and control using [11C]BU99008 under ongoing trial (Wilson et al., 2019).”
MethodThe link between neuroinflammation and the neurovascular unit in synucleinopathies
Wang, Q., Zheng, J., Pettersson, S., Reynolds, R., & Tan, E.-K. (2023) · Science Advances · doi:10.1126/sciadv.abq1141 · Cited by 81
Metadata
- Authors
- Wilson, H., Dervenoulas, G., Pagano, G., Tyacke, R. J., Polychronis, S., Myers, J., Gunn, R. N., Rabiner, E. A., Nutt, D., & Politis, M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-08-26
- Volume
- 142
- Issue
- 10
- Pages
- 3116-3128
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2970592309
- Cited by
- 92
- References
- 14
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.